Generics giant Teva Pharmaceuticals will pay $450 million over six years to settle two allegations that the company violated ...

As European manufacturers localize their supply chains and production, they are also warning that drug prices could creep up ...

A small venture capital firm that backs up-and-coming scientists plans to raise a $35 million second fund, three years after ...

In early-stage trials called dose escalation studies, drug developers usually want to test progressively higher doses of ...

Just over a year after going public, Turnstone Biologics is axing staff, adjusting its leadership team and changing its ...

Eli Lilly has joined the club of pharma companies that have lined up AI execs. Thomas Fuchs will be Lilly’s first-ever chief ...

Boston-area biotechs Upstream Bio and CAMP4 Therapeutics are headed to the Nasdaq on Friday, the latest companies to IPO in ...

The FDA has approved Roche’s inavolisib plus Pfizer's Ibrance and fulvestrant in a subtype of breast cancer over a month ...

The phar­ma in­dus­try’s DC-based lob­by­ing group urged the fed­er­al gov­ern­ment on Fri­day to get on board with ...

Heart-breaking anecdotes from the patients, parents and doctors of children with the ultra-rare and fatal Barth syndrome won ...

Seven young boys treated with bluebird bio’s gene therapy for a rare neurological disease have been diagnosed with blood ...